---
title: "Final Update Antipsychotics Project"
subtitle: "I¬¥m so glad &#x1F602;&#x1F44F;"
format: 
  revealjs:
    theme: [default, custom.scss]
    slide-number: true
editor: source
incremental: true

---
## Differentially Methylated Regions <br> associated with antipsychotic treatment <br> <br> <br> <br> <br> Martens Summer Seminar <br> June 17, 2024 {background-color="black" background-image="img/summerFlowers.jpg" background-size="cover" background-opacity="0.7"}



## Aim: Identification of treatment effects <br>

-  Olanzapine, quetiapine, risperidone 
-  Our focus - DNA methylation (CpG or DMR level) 
-  Epigenetic dysregulation in severe mental illness is complex
-  Evidence from animal models and cells lines

::: footer
Martens Summer Seminar 2024
:::

## Epigenetic Modifications/Factors 


![](img/Smigielski.png)

##

![](img/Smigielski.png)

## 
Dysregulation of epigenetic processes has been demonstrated in SCZ - not only in clinical studies, but also in animal models, cell lines, and postmortem brain studies. Not only DNAm. Epigenetic regulation is important, particularly during brain development (pre- and postnatally).  Epigenetic modifications are aslo involved in maintenance of sex differences in the brain (99) which may explain differences in susceptibility, onset, pathogenesis, and severity of SCZ between males and females (100). 

::: footer
Martens Summer Seminar 2024
:::

## Sample Selection {.smaller}

:::: columns

::: {.column width="40%"}

![](img/Sample_Selection.500.png){.absolute top=90 width=300px}

:::

::: {.column width="60%"}
<br>
<p>[SCZ, BPD, MDD]{.highlight}</p>

<br> Same monotherapy AP samples for both groups <br><br> Olanzapine, Quetiapine, Risperidone <br><br> Included Med-free in Specific Effects group    

:::

::::

## Methods

- Common 
Model: ùõΩ ~ AP-serum + Sex + Age + Smoking score + Diagnosis + Technical batch + Cell counts <br><br> 

- Specific 
Model: ùõΩ ~ AP vs (Other AP + MF) + Sex + Age + Smoking score + Diagnosis + Technical batch + Cell counts <br><br> 

- Differentially methylated region analysis (DMRs) __dmrff__

- Database investigation of DMR-annotated genes e.g. SynGO, GeneTrail 3.2, EpiFactors 2022


## Results: Common Effects Analysis n=136 {.smaller}

:::: columns

:::{.column width="70%"}

![](img/CommonEffectsDMRsb.png)

:::

::: {.column width="30%"}

<br> Meta-analysis EWAS results<br>
<br> 22 DMRs FDR < 0.05 <br><br> 
16 DMRs FDR < 0.01 <br><br>  

:::

::::

## Results: Specific Effects Analysis n=263 <br><br>

![](img/SpecificDMRs.png)



## Database investigation of DMR genes<br><br>


![](img/GeneTrail3.2.png)

::: footer
Martens Summer Seminar 2024
:::   

## Database investigation of DMR genes <br><br>

![](img/SynGO.png)

::: footer
Martens Summer Seminar 2024
:::

## Database investigation of DMR genes <br><br>


![](img/EpiFactors.png)

::: footer
Martens Summer Seminar 2024
:::

## Results: Common Effects

Genes associated with chromatin compaction/gene silencing

![](img/CommonEffects_EpiFactors.png)



::: footer
[EpiFactors](https://epifactors.autosome.org)
:::

## Results: Specific Effects Olanzapine

Genes associated with methyltransferases/gene silencing

![](img/Ola_EpiFactors.png)


::: footer
[EpiFactors](https://epifactors.autosome.org)
:::

## Results: Specific Effects Quetiapine

Genes associated with 

![](img/Que_EpiFactors.png)

::: footer
[EpiFactors](https://epifactors.autosome.org)
:::

## Results: Specific Effects Risperidone

Genes associated with chromatin easing/gene transcription

![](img/Ris_EpiFactors.png)

::: footer
[EpiFactors](https://epifactors.autosome.org)
:::

## Discussion/Conclusion

- Real world studies also challenging
- Median study duration 6 weeks, maximum 13 weeks (PMID:37159349)
- 


::: footer
Leucht et al.(2013) **World Psychiatry**
:::